AstraZeneca to Pay Inovio Up to $700 Million for Cancer Drug

Yahoo NewsAstraZeneca to Pay Inovio Up to $700 Million for Cancer DrugBloombergAstraZeneca Plc agreed to pay Inovio Pharmaceuticals Inc. as much as $727.5 million for rights to an experimental cancer vaccine, its third deal in a week to secure access to new tumor-fighting drugs. AstraZeneca's Medimmune unit will pay Plymouth ...AstraZeneca bags another cancer drug deal, this time with InovioYahoo NewsInovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and ...CNNMoneyall 16 news articles »

Share this post